2236P MHC-II neoantigens and copy number alterations (CNA) drive immune checkpoint inhibitor (ICI) response in metastatic melanoma (MM)

Benjamin Shum ,A.C Gault,E Peleva,S El Badri,L.M Pickering,P Kissoonsingh,James Larkin ,Leila Khoja ,Richard Marais ,Kevin Litchfield ,Sharon H Nahm ,Paul Lorigan ,Nathalie Dhomen ,Prabhu Arumugam ,Irene Lobón ,Tom Lesluyes ,Sarah Danson ,Alberto Fusi ,Husayn Ahmed Pallikonda ,Samra Turajlic

doi:10.1016/j.annonc.2023.09.1264

2236P MHC-II neoantigens and copy number alterations (CNA) drive immune checkpoint inhibitor (ICI) response in metastatic melanoma (MM)

Benjamin Shum , A.C Gault + Show 18 more

Open Access

https://doi.org/10.1016/j.annonc.2023.09.1264

Copy DOI

Journal: Annals of Oncology

Publication Date: Oct 1, 2023

#Copy Number Alterations #Immune Checkpoint Inhibitor + Show 6 more

Abstract
Full-Text PDF
Similar Papers

Abstract

2236P MHC-II neoantigens and copy number alterations (CNA) drive immune checkpoint inhibitor (ICI) response in metastatic melanoma (MM)

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.